India Globalization Capital’s CEO to Speak at CEO Healthcare Symposium in NY on February 12 & 13
February 12, 2018 08:00 ET
|
ram mukunda
BETHESDA, Md., Feb. 12, 2018 (GLOBE NEWSWIRE) --
India Globalization Capital, Inc. (NYSE-MKT:IGC) announced today that Ram Mukunda will be a speaker at the upcoming CEO Healthcare Symposium...
Peregrine Pharmaceuticals Announces First Patient Dosed in Phase II Clinical Trial Evaluating Bavituximab Treatment Combination in Patients with Newly Diagnosed Glioblastoma
September 07, 2017 08:10 ET
|
Peregrine Pharmaceuticals Inc.
TUSTIN, Calif., Sept. 07, 2017 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a biopharmaceutical company committed to improving patient lives by manufacturing...
IGC Provides Update on Phytocannabinoid IP Portfolio
November 02, 2016 09:32 ET
|
India Globalization Capital
BETHESDA, Md., Nov. 02, 2016 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE MKT:IGC) announces updates for five patents related to method and treatment of pain, seizures and eating...
IGC Announces Financial Results for Fiscal Year Ended March 31, 2016
July 18, 2016 08:30 ET
|
India Globalization Capital
BETHESDA, Md., July 18, 2016 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE MKT:IGC) announces financial results for the fiscal year ended March 31, 2016. Total revenue was...